PMID- 23805237 OWN - NLM STAT- MEDLINE DCOM- 20171006 LR - 20220310 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 6 DP - 2013 TI - Interleukin-10 -592C/A, -819C/T and -1082A/G Polymorphisms with Risk of Type 2 Diabetes Mellitus: A HuGE Review and Meta-analysis. PG - e66568 LID - 10.1371/journal.pone.0066568 [doi] LID - e66568 AB - BACKGROUND: Several studies have been conducted in recent years to evaluate the risk of type 2 diabetes mellitus (T2DM) and polymorphisms of interleukin (IL)-10. However, the results remain conflicting rather than conclusive. This meta-analysis aimed to summarize the current evidence from case-control studies that evaluated this association. METHODS: We carried out a search in Medline, EMBASE, and the Chinese National Knowledge Infrastructure (CNKI) database for relevant studies. Data were extracted using a standardized form and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the strength of the association. RESULTS: 10 studies were included in our meta-analysis and systemic review. Our meta-analysis indicated that IL-10 -1082A/G polymorphism was associated with the risk of T2DM (GA vs. AA: OR = 1.21, 95% CI = 1.03-1.14; GA/GG vs. AA: OR = 1.22, 95% CI = 1.05-1.41), whereas there was no association between IL-10 -592C/A (CC/CA vs. AA: OR = 1.07, 95% CI = 0.59-1.93) or -819C/T (CC/CT vs. TT: OR = 0.93, 95% CI = 0.49-1.75) polymorphism and T2DM risk was found in our study. CONCLUSIONS: This meta-analysis provides strong evidence that IL-10 -1082A/G polymorphism associated with risk of T2DM. However, no association of the IL-10 -592C/A or -819C/T polymorphism with T2DM risk was found. Additional well-designed large studies were required for the validation of our results. FAU - Hua, Yanyin AU - Hua Y AD - Department of Endocrinology, Zhejiang Provincial People's Hospital, Hangzhou, China. FAU - Shen, Jie AU - Shen J FAU - Song, Yingxiang AU - Song Y FAU - Xing, Yubo AU - Xing Y FAU - Ye, Xiao AU - Ye X LA - eng PT - Journal Article PT - Meta-Analysis PT - Review DEP - 20130621 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (IL10 protein, human) RN - 130068-27-8 (Interleukin-10) SB - IM MH - Diabetes Mellitus, Type 2/*genetics MH - Female MH - *Genetic Predisposition to Disease MH - Humans MH - Interleukin-10/*genetics MH - Male MH - *Polymorphism, Genetic MH - Risk Factors PMC - PMC3689758 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/06/28 06:00 MHDA- 2013/06/28 06:01 PMCR- 2013/06/21 CRDT- 2013/06/28 06:00 PHST- 2013/03/26 00:00 [received] PHST- 2013/04/16 00:00 [accepted] PHST- 2013/06/28 06:00 [entrez] PHST- 2013/06/28 06:00 [pubmed] PHST- 2013/06/28 06:01 [medline] PHST- 2013/06/21 00:00 [pmc-release] AID - PONE-D-13-12836 [pii] AID - 10.1371/journal.pone.0066568 [doi] PST - epublish SO - PLoS One. 2013 Jun 21;8(6):e66568. doi: 10.1371/journal.pone.0066568. Print 2013.